Computer Aided Detection of Polyps in the Colon
NCT03925337 is an interventional trial sponsored by Beth Israel Deaconess Medical Center. As of 18 Nov 2026, it is completed. It studies Colo-rectal Cancer and Polyp, Adenomatous. The registry lists an enrollment of 234 participants at 4 sites in 1 country. The registry lists a start date of 7 May 2019 and a primary completion date of 24 Nov 2020.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03925337 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Beth Israel Deaconess Medical Center |
| Enrollment | 234 |
| Registered sites | 4 |
| Countries | 1 |
| Conditions | Colo-rectal Cancer and Polyp, Adenomatous |
| Start | 7 May 2019 |
| Primary completion | 24 Nov 2020 |
| Study completion | 12 May 2021 |
| Last update posted | 20 Jul 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Tyler M Berzin, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago
Chicago
- Beth Israel Deaconess Medical Center
Boston
- Nyu Langone
New York
- Baylor College of Medicine
Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03925337
Each answer restates registry values shown on this page.
What is NCT03925337?
NCT03925337 is an interventional trial sponsored by Beth Israel Deaconess Medical Center. It studies Colo-rectal Cancer and Polyp, Adenomatous.
Who leads NCT03925337?
The registry names Tyler M Berzin, MD (principal investigator, Beth Israel Deaconess Medical Center) as the overall official.
Where does NCT03925337 run?
The registry lists 4 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT03925337 end?
The registry lists a primary completion date of 24 Nov 2020 and a study completion date of 12 May 2021. The sponsor last updated the record on 20 Jul 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.